检索结果 - Weiyuan Chung

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure

    Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure 由 David S. Siegel, Gary J. Schiller, Kevin Song, Richy Agajanian, Keith Stockerl‐Goldstein, Hakan Kaya, Michaël Sébag, Christy Samaras, Ehsan Malek, Giampaolo Talamo, Christopher S. Seet, Jorge Mouro, William E. Pierceall, Faiza Zafar, Weiyuan Chung, Shankar Srinivasan, Amit Agarwal, Nizar J. Bahlis

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

    Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment 由 David S. Siegel, Gary J. Schiller, Christy Samaras, Michaël Sébag, Jesús G. Berdeja, Siddhartha Ganguly, Jeffrey Matous, Kevin Song, Christopher S. Seet, Giampaolo Talamo, Mirelis Acosta-Rivera, Michael Bär, Donald P. Quick, Bertrand Anz, Gustavo Fonseca, Donna Reece, William E. Pierceall, Weiyuan Chung, Faiza Zafar, Amit Agarwal, Nizar J. Bahlis

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: